About Javara Research
Javara Research is a company based in Winston-salem (United States) founded in 2018. Javara Research has raised $44.98 million across 5 funding rounds from investors including General Atlantic. Javara Research offers products and services including CRAACO Service and Infrastructure Provision. Javara Research operates in a competitive market with competitors including Vial, Alcanza Clinical Research, Global Coalition for Adaptive Research, Clinical Pharmacology of Miami and The START Center for Cancer Research, among others.
- Headquarter Winston-salem, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$44.98 M (USD)
in 5 rounds
-
Latest Funding Round
$6.6 M (USD), Series B
May 13, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Javara Research
Javara Research offers a comprehensive portfolio of products and services, including CRAACO Service and Infrastructure Provision.
Connects patients to trials at point of care for better access.
Offers training and infrastructure for conducting clinical trials efficiently.
People of Javara Research
Unlock access to complete
Unlock access to complete
Funding Insights of Javara Research
Javara Research has successfully raised a total of $44.98M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $6.6 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Javara Research
Javara Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include General Atlantic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on global markets
|
Locked | Locked | Locked |
Investor details for Javara Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Javara Research
Investment portfolio details for Javara Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Javara Research
Detailed financials for Javara Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Javara Research Comparisons
Peer comparison for Javara Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Javara Research
Javara Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vial, Alcanza Clinical Research, Global Coalition for Adaptive Research, Clinical Pharmacology of Miami and The START Center for Cancer Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Healthcare data capture, clinical trials, and CRO services are provided.
|
|
| Locked | Locked | Locked |
Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation
|
|
| Locked | Locked | Locked |
Nonprofit organization sponsors clinical trials for rare diseases worldwide.
|
|
| Locked | Locked | Locked |
Clinical research unit for phase I, II and III trials
|
|
| Locked | Locked | Locked |
Early-phase oncology clinical trials and research services are provided.
|
Detailed competitors of Javara Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Javara Research
Complete news archive for Javara Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Javara Research
Javara Research was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Javara Research is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.
Jennifer Byrne is the current CEO of Javara Research.
Javara Research is a funded company, having raised a total of $44.98M across 5 funding rounds to date.
Javara Research was founded in 2018 in Winston-Salem, United States, as a clinical research entity focused on the pharmaceutical sector. Trials are carried out in a broad spectrum of therapeutic areas, supported by an integrated platform designed for streamlined operations. Services encompass trial management and execution, with activities centered in the U.S. to facilitate industry partnerships and research advancements.
Javara Research's top competitors include Vial, The START Center for Cancer Research and Summit Clinical Research.
Javara Research offers CRAACO Service and Infrastructure Provision.
Javara Research has 1 investor. Key investors include General Atlantic.